Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Sarcomatosis
Reese W. Randle+5 more
openalex +1 more source
Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy [PDF]
Rebecca M. Dodson+7 more
openalex +1 more source
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate? [PDF]
Mangieri CW+3 more
europepmc +1 more source
An Updated Meta-Analysis on Long-Term Outcomes Following Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer. [PDF]
El Kassis N+7 more
europepmc +1 more source
Challenges of Nontherapeutic Laparotomy in Patients with Peritoneal Surface Malignancies Selected for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]
Gil-Gómez E+9 more
europepmc +1 more source
Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control [PDF]
Marco Petrillo+3 more
openalex +1 more source
Conversion Therapy for Gastric Cancer with Peritoneal Metastasis
Peritoneal metastasis in gastric cancer has a poor prognosis and is increasing in prevalence. Neoadjuvant chemotherapy is used for advanced tumors; however, surgery is generally not considered for metastatic and unresectable diseases.
Thita Intralawan+9 more
doaj
Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. [PDF]
Kim M+7 more
europepmc +1 more source